CVS Health Corporation (CVS): Jim Cramer Says You Don't Want Them Buying The Wrong Robots
We recently published a list of Jim Cramer Discusses Melting Trade Tensions & These 12 Stocks.
Cvs Health Corp (CVS)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Pzena Investment Management Richard S. Pzena | 17,682,374 | $1,197,980,839 | -10% | 4.18% |
| 2. | Glenview Capital Larry Robbins | 11,946,799 | $809,395,632 | 19.9% | |
| 3. | Citadel Investment Group Ken Griffin | 6,260,250 | $424,131,938 | -2% | 0.08% |
| 4. | Harris Associates Natixis Global Asset Management | 5,995,818 | $406,216,698 | +6% | 0.68% |
| 5. | Holocene Advisors Brandon Haley | 5,928,174 | $401,633,789 | +125% | 1.17% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $63.70 | 1,570 | Director | 12,007 | 2025-06-05 | Filing | |
| $66.70 | 30,000 | Director | 39,356 | 2025-02-18 | Filing | |
| $53.88 | 1,000 | Director | 21,630 | 2024-05-02 | Filing | |
| $54.49 | 9,181 | Director | 9,356 | 2024-05-02 | Filing | |
| $70.47 | 2,000 | Director | 20,630 | 2023-11-03 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $66.67 | 150,000 | 8,196,799 | 2025-05-06 | Filing | ||
| $67.99 | 96,999 | 8,346,799 | 2025-05-05 | Filing | ||
| $67.37 | 1,226,933 | 8,443,798 | 2025-05-05 | Filing | ||
| $69.66 | 373,776 | 9,670,731 | 2025-05-02 | Filing | ||
| $68.38 | 222,556 | 10,044,507 | 2025-05-02 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 118,335,394 | $8,017,222,944 | 0.14% | |
| 2. | 112,593,476 | $7,628,207,985 | 0.16% | |
| 3. | 73,459,122 | $4,976,855,516 | 2.84% | |
| 4. | 68,398,405 | $4,633,841,718 | 0.75% | |
| 5. | 57,988,171 | $3,928,698,585 | 0.16% |
News See All
CVS Health (CVS) Maintains Overweight Rating at Cantor Amid Membership Data Discrepancies
Cantor Fitzgerald analysts reaffirmed their price target of $71 and Overweight rating on CVS Health Corporation (NYSE:CVS) on June 4.
Jim Cramer Discusses Melting Trade Tensions & These 12 Stocks
In a recent appearance on Squawk on the Street, Jim Cramer discussed fluctuations in stock market futures.
CVS Health Corporation (CVS) Unveils $20 Billion Plan to Improve Customer Healthcare Experience
CVS Health Corporation (NYSE:CVS) plans to invest $20 billion over the next decade to create a more technology-driven consumer healthcare experience, aiming to ease many of the challenges within the US...
JP Morgan Keeps Faith in UnitedHealth (UNH) Amid Regulatory Reviews
On May 21, after the market closed, the Centers for Medicare and Medicaid Services (CMS) announced an expansion of its risk adjustment data validation (RADV) audits for Medicare Advantage plans.
Here’s Why CVS Health Corp. (CVS) Traded Higher in Q1
Hotchkis & Wiley, an investment management company, released its “Hotchkis & Wiley Mid-Cap Value Fund” first quarter 2025 investor letter. A copy of the letter can be downloaded here.
10 Unstoppable Dividend Stocks to Buy Now
Dividend-paying stocks are drawing increased attention from investors amid this year’s market volatility.
Rite Aid to Sell Majority of U.S. Pharmacy Operations to Rivals, Including CVS Health Corporation (CVS)
Rite Aid has sold the pharmacy operations of more than 1,000 of its U.S.
11 Best Performing Healthcare Stocks to Buy Now
On April 15, CNBC reported that President Trump's healthcare-focused executive order brought in a win for the sector.
Jim Cramer Reveals Trump's Potential Secret Weapon In China Trade Talks & Discusses These 10 Stocks
In a recent appearance on CNBC's Squawk on the Street, Jim Cramer discussed the impacts that tariffs have had on businesses.
Billionaire Hedge Funds
